HPR174 Authorization and Financing Situation in Spain of the New Medicines and Indications Authorized by the European Commission in the Period 2021-2023
Abstract
Authors
J. Sánchez-Martín N. López-Martínez J Jara M Cuesta J. Costa-Samarra J Armengol